Learning Objectives:

1. Discuss the diagnosis and classification of neuroendocrine tumors

2. Discuss the treatment landscape of NETs

3. Discuss the role of Peptide Receptor Radionuclide Therapy (PRRT) in NET treatment

4. Discuss the role of aggressive surgical therapy (debulking) for neuroendocrine tumor patients

5. Discuss the role of liver directed therapy for neuroendocrine tumor patients

6. Discuss the risks and benefits of modern systemic therapies for neuroendocrine tumor patients, including peptide receptor radionuclide therapy 

Session date: 
08/16/2021 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Chih-Yi "Andy" Liao, MD; Xavier Keutgen, MD; Osman Ahmed, MD